Literature DB >> 23794067

The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.

Marinos Kallikourdis1, Anna Elisa Trovato, Fabio Anselmi, Adelaida Sarukhan, Giuliana Roselli, Laura Tassone, Raffaele Badolato, Antonella Viola.   

Abstract

WHIM (warts, hypogammaglobulinemia, infections, myelokathexis) syndrome is a rare disease characterized by diverse symptoms indicative of aberrantly functioning immunity. It is caused by mutations in the chemokine receptor CXCR4, which impair its intracellular trafficking, leading to increased responsiveness to chemokine ligand and retention of neutrophils in bone marrow. Yet WHIM symptoms related to adaptive immunity, such as delayed IgG switching and impaired memory B-cell function, remain largely unexplained. We hypothesized that the WHIM-associated mutations in CXCR4 may affect the formation of immunologic synapses between T cells and antigen-presenting cells (APCs). We show that, in the presence of competing external chemokine signals, the stability of T-APC conjugates from patients with WHIM-mutant CXCR4 is disrupted as a result of impaired recruitment of the mutant receptor to the immunologic synapse. Using retrogenic mice that develop WHIM-mutant T cells, we show that WHIM-mutant CXCR4 inhibits the formation of long-lasting T-APC interactions in ex vivo lymph node slice time-lapse microscopy. These findings demonstrate that chemokine receptors can affect T-APC synapse stability and allow us to propose a novel mechanism that contributes to the adaptive immune response defects in WHIM patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23794067      PMCID: PMC3731928          DOI: 10.1182/blood-2012-10-461830

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Unexpected developments in immune organs in WHIM syndrome.

Authors:  Philip M Murphy; David H McDermott
Journal:  Blood       Date:  2012-06-14       Impact factor: 22.113

2.  Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice.

Authors:  Karl Balabanian; Emilie Brotin; Vincent Biajoux; Laurence Bouchet-Delbos; Elodie Lainey; Odile Fenneteau; Dominique Bonnet; Laurence Fiette; Dominique Emilie; Françoise Bachelerie
Journal:  Blood       Date:  2012-03-20       Impact factor: 22.113

3.  Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome.

Authors:  Peter J Mc Guire; Charlotte Cunningham-Rundles; Hans Ochs; George A Diaz
Journal:  Clin Immunol       Date:  2010-03-11       Impact factor: 3.969

4.  A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome.

Authors:  Ken Y C Chow; Émilie Brotin; Youcef Ben Khalifa; Laetitia Carthagena; Sébastien Teissier; Anne Danckaert; Jean-Luc Galzi; Fernando Arenzana-Seisdedos; Françoise Thierry; Françoise Bachelerie
Journal:  Cell Host Microbe       Date:  2010-12-16       Impact factor: 21.023

5.  Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation.

Authors:  S K Bromley; D A Peterson; M D Gunn; M L Dustin
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

6.  The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.

Authors:  David H McDermott; Qian Liu; Jean Ulrick; Nana Kwatemaa; Sandra Anaya-O'Brien; Scott R Penzak; Joao Oliveira Filho; Debra A Long Priel; Corin Kelly; Mary Garofalo; Patricia Littel; Martha M Marquesen; Diane Hilligoss; Rosamma Decastro; Thomas A Fleisher; Douglas B Kuhns; Harry L Malech; Philip M Murphy
Journal:  Blood       Date:  2011-09-02       Impact factor: 22.113

Review 7.  WHIM syndrome: congenital immune deficiency disease.

Authors:  Toshinao Kawai; Harry L Malech
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

8.  CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway.

Authors:  Kathrin Gollmer; François Asperti-Boursin; Yoshihiko Tanaka; Klaus Okkenhaug; Bart Vanhaesebroeck; Jeffrey R Peterson; Yoshinori Fukui; Emmanuel Donnadieu; Jens V Stein
Journal:  Blood       Date:  2009-05-18       Impact factor: 22.113

9.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

Authors:  Isabelle Petit; Martine Szyper-Kravitz; Arnon Nagler; Meir Lahav; Amnon Peled; Liliana Habler; Tanya Ponomaryov; Russell S Taichman; Fernando Arenzana-Seisdedos; Nobutaka Fujii; Judith Sandbank; Dov Zipori; Tsvee Lapidot
Journal:  Nat Immunol       Date:  2002-06-17       Impact factor: 25.606

10.  PLC-gamma2 is essential for formation and maintenance of memory B cells.

Authors:  Masaki Hikida; Stefano Casola; Noriko Takahashi; Tomohiro Kaji; Toshitada Takemori; Klaus Rajewsky; Tomohiro Kurosaki
Journal:  J Exp Med       Date:  2009-03-09       Impact factor: 14.307

View more
  19 in total

Review 1.  Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.

Authors:  Bertrand Boisson; Pierre Quartier; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2015-01-31       Impact factor: 7.486

2.  Adenosine triphosphate acts as a paracrine signaling molecule to reduce the motility of T cells.

Authors:  Chiuhui Mary Wang; Cristina Ploia; Fabio Anselmi; Adelaida Sarukhan; Antonella Viola
Journal:  EMBO J       Date:  2014-05-19       Impact factor: 11.598

Review 3.  Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Authors:  Philip M Murphy; Lauren Heusinkveld
Journal:  Cytokine       Date:  2018-02-15       Impact factor: 3.861

4.  Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib.

Authors:  Aaron T Gerds; Tetsuzo Tauchi; Ellen Ritchie; Michael Deininger; Catriona Jamieson; Ruben Mesa; Mark Heaney; Norio Komatsu; Hironobu Minami; Yun Su; Naveed Shaik; Xiaoxi Zhang; Christine DiRienzo; Mirjana Zeremski; Geoffrey Chan; Moshe Talpaz
Journal:  Leuk Res       Date:  2019-02-28       Impact factor: 3.156

Review 5.  New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.

Authors:  Seth J Corey; Usua Oyarbide
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Small interference ITGA6 gene targeting in the human thymic epithelium differentially regulates the expression of immunological synapse-related genes.

Authors:  Daiane Cristina F Golbert; Eliane Santana-Van-Vliet; Marcelo Ribeiro-Alves; Marbella Maria B da Fonsêca; Ailin Lepletier; Daniella Arêas Mendes-da-Cruz; Guilherme Loss; Vinícius Cotta-de-Almeida; Ana Tereza R Vasconcelos; Wilson Savino
Journal:  Cell Adh Migr       Date:  2017-08-30       Impact factor: 3.405

7.  Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors.

Authors:  Concepción Gómez-Moutón; Thierry Fischer; Rosa M Peregil; Sonia Jiménez-Baranda; Thomas P Stossel; Fumihiko Nakamura; Santos Mañes
Journal:  Blood       Date:  2014-10-29       Impact factor: 22.113

Review 8.  WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.

Authors:  Lauren E Heusinkveld; Shamik Majumdar; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  J Clin Immunol       Date:  2019-07-16       Impact factor: 8.317

9.  Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.

Authors:  Lauren E Heusinkveld; Erin Yim; Alexander Yang; Ari B Azani; Qian Liu; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  Expert Opin Orphan Drugs       Date:  2017-09-25       Impact factor: 0.694

Review 10.  At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.

Authors:  Gary D Luker; Jinming Yang; Ann Richmond; Stefania Scala; Claudio Festuccia; Margret Schottelius; Hans-Jürgen Wester; Johann Zimmermann
Journal:  J Leukoc Biol       Date:  2020-10-26       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.